Redmile Group, LLC, 10% Owner at Entrada Therapeutics, Inc. (TRDA), bought 1,954,420 shares at $20.00 ($20.0M) on 2021-11-02, disclosed to the SEC on 2021-11-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 954,420 | $0 | 0.0% |
| 2 | $20.00 | 1,000,000 | $20.0M | 100.0% |
| Total | $10.23 avg | 1,954,420 | $20.0M | 100% |
| Filing → |
| FATE | BUY | 2023-12-28 | $332K | — | Filing → |
| IGMS | BUY | 2023-07-03 | $1.5M | — | Filing → |
| IGMS | SELL | 2023-07-03 | $1.5M | — | Filing → |